ArticleThe British journal of dermatology2020
New brodalumab psoriasis outcome data suggests that intermittent treatment is as effective as continuous dosing. Is it time to re-evaluate our treatment regimens?
P Babakinejad et al.PubMed ↗Publisher ↗
No numbers read from the abstract.